230 citations
- Université Paris CitéFR8 papers
- Centre National de la Recherche ScientifiqueFR7 papers
- InsermFR7 papers
- Sorbonne UniversitéFR4 papers
- Université Paris Sciences et LettresFR4 papers
- Institut PasteurFR3 papers
- Sorbonne Paris CitéFR3 papers
- CERMICSFR2 papers
- Commissariat à l'Énergie Atomique et aux Énergies AlternativesFR2 papers
- École nationale des ponts et chausséesFR2 papers
- École Nationale Supérieure des Mines de ParisFR2 papers
- École Normale Supérieure de LyonFR2 papers
6 papers · 1 filter
Calibrating confounding strength in sensitivity models for weighting estimators: a comparative review and a new method
Jean-Baptiste Baitairian, Bernard Sebastien, Rana Jreich +2
Causal inference is only valid when its underlying assumptions are satisfied, one of the most central being the ignorability or unconfoundedness assumption. However, this hypothesi…
Treatment Effect Estimation in Causal Survival Analysis: Practical Recommendations
Charlotte Voinot, Clément Berenfeld, Imke Mayer +2
The restricted mean survival time (RMST) difference offers an interpretable causal contrast to estimate the treatment effect for time-to-event outcomes, yet a wide range of availab…
Sharp Bounds for Continuous-Valued Treatment Effects with Unobserved Confounders
Jean-Baptiste Baitairian, Bernard Sebastien, Rana Jreich +2
In causal inference, treatment effects are typically estimated under the ignorability, or unconfoundedness, assumption, which is often unrealistic in observational data. By relaxin…
Variable selection in high-dimensional logistic regression models using a whitening approach
Wencan Zhu, Céline Lévy-Leduc, Nils Ternès
In bioinformatics, the rapid development of sequencing technology has enabled us to collect an increasing amount of omics data. Classification based on omics data is one of the cen…
Bayesian dose-regimen assessment in early phase oncology incorporating pharmacokinetics and pharmacodynamics
Emma Gerard, Sarah Zohar, Hoai-Thu Thai +3
Phase I dose-finding trials in oncology seek to find the maximum tolerated dose (MTD) of a drug under a specific schedule. Evaluating drug-schedules aims at improving treatment saf…
A variable selection approach for highly correlated predictors in high-dimensional genomic data
Wencan Zhu, Céline Lévy-Leduc, Nils Ternès
In genomic studies, identifying biomarkers associated with a variable of interest is a major concern in biomedical research. Regularized approaches are classically used to perform…